HomeTable of contents
Table of contents
January 2024 - Volume 2 - 1
Editorial
14 February 2024•
Perspectives of mitochondria-lysosome-related organelle in hepatocyte dedifferentiation and implications in chronic liver diseaseXiaowen Ma, Hong-Min Ni, Wen-Xing Ding
Review
29 March 2024•
Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive reviewChristina Villard, Carl Jorns, Annika Bergquist
20 March 2024•
Extracellular vesicles targeting non-parenchymal cells: the therapeutical effect on liver fibrosisYingying Liu, Lin Wang
19 February 2024•
Spleen stiffness measurement as a non-invasive assessment in patients with portal hypertensionXiaoming Xu, Jiacheng Liu, Yixuan Zhu, Fajuan Rui, Chao Wu, Jie Li
22 January 2024•
Incorporating biological and clinical insights into variant choice for Mendelian randomisation: examples and principlesStephen Burgess, Héléne Toinét Cronjé
18 January 2024•
Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: advances and future directionsRobert D Little, Thisun Jayawardana, Sabrina Koentgen, Fan Zhang, Susan J Connor, Alex Boussioutas, Mark G Ward, Peter R Gibson, Miles P Sparrow, Georgina L Hold
Original research
26 March 2024•
ABCC2 p.R393W variant contributes to Dubin-Johnson syndrome by targeting MRP2 to proteasome degradationRong-Yue Sun, Yi-Ming Chen, Mian-Mian Zhu, Ji-an Sun, Hong-Wei Wang, Chen-Yu Wu, Ting Zhu, Yu-Jing Gong, Chao-Sheng Lu, Luisa Ronzoni, Luca Valenti, Ming-Hua Zheng, Dan Wang
22 January 2024•
Prevalence and prediction of hepatocellular carcinoma in alcohol-associated liver disease: a retrospective study of 136 571 patients with chronic liver diseasesBinxia Chang, Hui Tian, Ang Huang, Xingran Zhai, Qiaoling Wang, Lin Han, Xueyuan Jin, Li Gao, Qingsheng Liang, Baosen Li, Yinying Lu, Huan Xie, Dong Ji, Zhengsheng Zou